World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
75
Citations
29343
World Ranking
18991
National Ranking
9466

Robert L. Wilensky publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Robert L. Wilensky sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 274 publications — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Robert L. Wilensky D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Robert L. Wilensky sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 75 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 1997 - ACM Fellow For research contributions to the areas of natural language processing and digital libraries as well as outstanding leadership in Computer Science.

Overview

Robert L. Wilensky is affiliated with the University of Pennsylvania in the United States. Their research primarily focuses on Medicine with a strong emphasis on Cardiology and Cardiovascular Medicine, Surgery, Hepatology, Economics and Econometrics, and Pulmonary and Respiratory Medicine.

The scientist's recent publications cover a range of topics within these fields. Notable works include:

  • "Prospective CYP2C19 Genotyping to Guide Antiplatelet Therapy Following Percutaneous Coronary Intervention" (2020) published in Circulation Genomic and Precision Medicine
  • "Management of spontaneous coronary artery dissection: Trends over time" (2023) published in Vascular Medicine
  • "Impact Of Cirrhosis On 90-Day Outcomes After Percutaneous Coronary Intervention (from A Nationwide Database)" (2020) published in The American Journal of Cardiology
  • "One-Year Outcomes of Percutaneous Coronary Intervention in Patients with End-Stage Liver Disease" (2020) published in Clinical Medicine Insights Cardiology
  • "Stent-based delivery of AAV2 vectors encoding oxidation-resistant apoA1" (2022) published in Scientific Reports

Research topics covered by the scientist include:

  • Cardiovascular Issues in Pregnancy
  • Cardiac Structural Anomalies and Repair
  • Liver Disease and Transplantation
  • Abdominal Vascular Conditions and Treatments
  • Coronary Interventions and Diagnostics
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Lipoproteins and Cardiovascular Health

Frequent co-authors collaborating with the scientist are:

  • William Matthai
  • Jay Giri
  • Elizabeth Thompson
  • Jennifer Lewey
  • Daniel Y. Lu

The scientist has published articles in several journals, among them:

  • Circulation Genomic and Precision Medicine
  • Vascular Medicine
  • Clinical Medicine Insights Cardiology
  • The American Journal of Cardiology
  • Scientific Reports

Robert L. Wilensky was recognized as an ACM Fellow in 1997 for research contributions to the areas of natural language processing and digital libraries as well as outstanding leadership in Computer Science.

Best Publications

  • Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.

    Struan F. A. Grant;Gudmar Thorleifsson;Inga Reynisdottir;Rafil Benediktsson

  • Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis

    Amit V. Khera;Marina Cuchel;Margarita de la Llera-Moya;Amrith Rodrigues

  • A variant in CDKAL1 influences insulin response and risk of type 2 diabetes.

    Valgerdur Steinthorsdottir;Gudmar Thorleifsson;Inga Reynisdottir;Rafn Benediktsson

  • Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants.

    Sekar Kathiresan;Benjamin F Voight;Shaun Purcell;Kiran Musunuru

  • Stent-Based Delivery of Sirolimus Reduces Neointimal Formation in a Porcine Coronary Model

    Takeshi Suzuki;Greg Kopia;Shin Ichiro Hayashi;Lynn R. Bailey

  • Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes

    Julius Gudmundsson;Patrick Sulem;Valgerdur Steinthorsdottir;Jon T. Bergthorsson

  • A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction.

    Toby Freyman;Glenn Polin;Hashim Osman;Jody Crary

  • Thrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality, Major Bleeding, and Intracranial Hemorrhage: A Meta-analysis

    Saurav Chatterjee;Anasua Chakraborty;Ido Weinberg;Mitul Kadakia

  • Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial

    David E Kandzari;Michael Böhm;Felix Mahfoud;Felix Mahfoud;Raymond R Townsend

  • Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial

    Raymond R Townsend;Felix Mahfoud;Felix Mahfoud;David E Kandzari;Kazuomi Kario

  • Meta-analysis and imputation refines the association of 15q25 with smoking quantity

    Jason Z. Liu;Federica Tozzi;Dawn M. Waterworth;Sreekumar G. Pillai

  • Fenoldopam Mesylate for the Prevention of Contrast-Induced Nephropathy: A Randomized Controlled Trial

    Gregg W. Stone;Peter A. McCullough;James A. Tumlin;Norman E. Lepor

  • Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution

    Agnar Helgason;Snæbjörn Pálsson;Snæbjörn Pálsson;Gudmar Thorleifsson;Struan F A Grant;Struan F A Grant

  • Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial

    Michael Böhm;Kazuomi Kario;David E. Kandzari;Felix Mahfoud;Felix Mahfoud

  • Inactivating mutations in NPC1L1 and protection from coronary heart disease

    Nathan O. Stitziel;Hong Hee Won;Alanna C. Morrison;Gina M. Peloso

  • Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function

    Cristian Pattaro;Alexander Teumer;Mathias Gorski;Audrey Y. Chu

  • Volume-to-creatinine clearance ratio : A pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention

    Warren K. Laskey;Charles Jenkins;Faith Selzer;Oscar C. Marroquin

  • Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development

    Robert L Wilensky;Yi Shi;Emile R Mohler;Damir Hamamdzic

  • Fenoldopam Mesylate for the Prevention of Contrast-Induced Nephropathy

    Gregg W. Stone;Peter A. McCullough;James A. Tumlin;Norman E. Lepor

  • Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

    A.V. Khera;M. Cuchel;M. de la Llera-moya

Frequent Co-Authors

Emile R. Mohler
Emile R. Mohler University of Pennsylvania
Daniel J. Rader
Daniel J. Rader University of Pennsylvania
Alice K. Jacobs
Alice K. Jacobs Boston University
David O. Williams
David O. Williams Brigham and Women's Hospital
Muredach P. Reilly
Muredach P. Reilly Columbia University
Katherine M. Detre
Katherine M. Detre University of Pittsburgh
Unnur Thorsteinsdottir
Unnur Thorsteinsdottir deCODE Genetics (Iceland)
Kari Stefansson
Kari Stefansson deCODE Genetics (Iceland)
David P. Faxon
David P. Faxon Brigham and Women's Hospital
Howard C. Herrmann
Howard C. Herrmann University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related healthcare careers can offer flexibility and open doors beyond traditional medicine. Medical billing and coding schools with financial aid provide convenient pathways into vital administrative roles that support the healthcare industry. These programs often offer flexible schedules and financial support, making them accessible for a range of students.

For aspiring nurses, there are LPN to RN programs without TEAS test requirements. These innovative options help current practical nurses advance their careers more quickly and reduce barriers to vital nursing credentials.

If you're interested in healthcare leadership, consider an accelerated healthcare administration degree. These online programs allow students to enter management positions in hospitals, clinics, and other healthcare settings faster than ever before.

Lastly, registered nurses looking to specialize can explore ADN to FNP programs. These bridge programs enable nurses to advance to the role of Family Nurse Practitioner, expanding their clinical expertise and career opportunities.

Best Scientists Citing Robert L. Wilensky

Trending Scientists

Recently Published Articles